News

Elanco and Aratana Therapeutics finalize deal to merge

Elanco Animal Health has acquired Aratana Therapeutics. Structured as a stock-for-stock transaction, the deal was accepted by Aratana stockholders. "Aratana's strong position in the specialty market—with its current portfolio and pipeline—complements Elanco's field presence and capitalizes on new opportunities for key existing Elanco pet therapy brands," says Jeff Simmons, president and chief executive officer of Elanco. "This deal furthers Elanco's value-generating innovation, portfolio, and productivity (IPP) strategy, while continuing to bring great value to veterinarians and pet owners." Aratana produces Galliprant, a canine NSAID for osteoarthritis for which Elanco has had the exclusive rights to develop, manufacture, and commercialize since 2016. Aratana also contributes two additional products to Elanco's portfolio: Entyce, the only FDA-approved veterinary therapeutic to stimulate appetite in dogs, and Nocita, a long-acting local anesthetic that provides up to 72 hours of post-operative pain relief following certain surgeries in dogs and cats. Further, Aratana's research and development pipeline will contribute to Elanco's efforts to sustain the introduction of novel and innovative companion animal therapeutics. As a result of the acquisition, Elanco says it is forming a new commercial team dedicated to the veterinary specialty business into which the Aratana field force will transition. This specialty sales force will …

AAFP releases educational toolkit for feline diabetes

Managing and treating feline diabetes mellitus can be complicated, which is why the American Association of Feline Practitioners (AAFP) is releasing a Diabetes Educational Toolkit. A digital information source, the online toolkit provides veterinarians with the most relevant diagnostic and treatment information for diabetes mellitus, which is not always easy to diagnose. Further, veterinary professionals can access and gather information quickly via navigation tabs. Users can move directly to information focusing on diagnosis, treatment, remission strategy, troubleshooting, frequently asked questions, and client resources. According to AAFP, cats with diabetes mellitus require a customized treatment plan, including frequent reassessment and adjustments. The association notes that patient goals, finances, implementation of the treatment plan, and the patient's response are all aspects of effective treatment. "We are excited to release this digital resource to the veterinary community in hopes we can help veterinary professionals in the diagnosis and treatment of their diabetic feline patients through providing easy-to-access information that can be implemented for each cat," says Apryl Steele, DVM, president of AAFP's board of directors. "The purpose is to create more informed veterinary teams, as well as cat caregivers. This Diabetes Educational Toolkit is intended to be an on-the-ground tool for veterinary professionals …